A Malvern Instruments' Bioscience Development Initiative
Dynamic light scattering (DLS) is an analytical technique used to measure the particle size distribution of protein formulations across the oligomer and sub-micron size ranges of approximately 1 nm to 1 µm. The popularity of DLS within the biopharmaceutical industry is a consequence of the technique’s wide working size and extended sample concentration ranges, as well as its low volume requirements. With that said, the challenge that remains with the application of DLS to protein therapeutic formulations is centered around data interpretation. This four-part white paper series examines common issues and questions surrounding the principles, measurements and analysis of DLS data and discusses how to minimize the time required for and increase the accuracy of acquiring and interpreting DLS data during the biotherapeutic development process. Here, in Part One of this series, we provide an overview of the key principles of DLS: theory, correlation statistics, deconvolution algorithms, and the intensity to mass transform.
Dynamic Light Scattering
Dynamic light scattering (DLS) is a technique which is often used to measure the particle size distribution of bioformulations. DLS has become a staple technology within the areas of bioformulation screening and development, and is routinely used for both monitoring and predicting the colloidal stability of protein formulations.
Brownian motion is defined as the random motion of particles in solution. This motion is a consequence of thermally driven collisions of solvent or dispersant molecules with the particles of interest.
The light scattered from a solution of particles diffusing under the influence of Brownian motion will fluctuate with time (Figure 1 - Left). Across long time intervals, the scattering trace appears to be representative of random fluctuations about a mean. When viewed on smaller time scales, however (inset in Figure 1 - Left), it is evident that the intensity trace is in fact not random, but composed of a series of continuous data points. This continuity is a consequence of the physical confinement of particles in positions very close to those they occupied just a short time earlier (Figure 1 - Right). In other words, over short time scales the particles have insufficient time to move very far from their initial positions, and as such, the intensity signals are similar or "correlated".
Figure 1: Intensity fluctuations for a solution of diffusing particles (left) and position dependent correlation of the scattering intensity (right).
The intensity correlation is a second order statistical technique for measuring the degree of non-randomness in an apparently random data set. When applied to a time-dependent intensity trace, the correlation coefficients (Gτ) are calculated as shown below, where τ is the delay time.
Typically, intensity autocorrelation coefficients are normalized, such that G(∞) = 1. For monochromatic laser light, this normalization imposes an upper correlation limit of 2 for G(τ0) and a lower baseline limit of 1 for G(∞). In practice, the experimental upper limit for DLS autocorrelation is about 1.9.
In dynamic light scattering instrumentation, a digital correlator continually adds and multiplies short time scale fluctuations in the measured scattering intensity to generate the correlation curve for the sample. Examples of DLS-measured correlation curves for two solutions of sub-micron particles are given in Figure 2. For the smaller and faster diffusing protein, ovalbumin, the measured correlation curve has decayed to baseline, indicating a complete loss of correlation within 100 µs, while the larger and more slowly diffusing silicon dioxide particle requires nearly 1000 µs before correlation is lost.
Figure 2: DLS measured correlation curves for 6 nm ovalbumin and 95 nm silicon dioxide.
Deconvolution (Fitting) Algorithms
For monodisperse samples consisting of a single particle size group, the correlation curve can be fitted to a single exponential form as given in the following expression, where B is the baseline, A is the amplitude, and D is the diffusion coefficient. The scattering vector (q) is defined by the second expression, where ñ is the solvent refractive index, λ0 is the vacuum wavelength of the laser, and θ is the scattering angle.
The hydrodynamic radius (RH) is defined as the radius of a hard sphere that diffuses at the same rate as the particle under examination. In DLS, RH is calculated from the measured diffusion coefficient using the Stokes-Einstein equation given below, where k is the Boltzmann constant, T is the temperature, and η is the dispersant viscosity.
A cumulant or single exponential type fit of the correlation curve is the fitting procedure recommended by ISO, the International Standards Organization. The hydrodynamic size extracted using this method is an "intensity" weighted average called the Z average size.
While the cumulant algorithm and Z average are useful for describing general solution characteristics, for multimodal solutions consisting of multiple particle size groups, the Z average can be underwhelming. For these types of samples, multi-exponential fitting algorithms can provide a more complete picture of the particle size distribution. Consider, for example, the correlogram shown in Figure 3 for a 10 mg/mL lysozyme sample in 100 mM NaCl at 69°C. This correlogram clearly exhibits two exponential decays: one for the fast-moving monomer at 3.5 nm and one for the slow-moving aggregate at 388 nm. The size distribution was derived by fitting the measured correlogram to a multi-exponential using the CONTIN algorithm. When the single exponential cumulant algorithm is used, a Z average of 12.4 nm is indicated. As evident here, the Z average, while beneficial for the purposes of citing a single average value, is clearly inadequate for giving a complete description of the distribution results.
Figure 3: DLS measurement results for 10 mg/mL lysozyme in 100 mM NaCl at 69°C, derived using multi-exponential CONTIN algorithm.
Intensity To Mass Transform
The area under each peak in the DLS-measured intensity particle size distribution is proportional to the relative scattering intensity of each particle family. The scattering intensity is proportional to the square of the molecular weight (or R6), and as such the intensity distribution will tend to be skewed towards larger particle sizes. While this behavior is expected, it can lead to some confusion for new DLS users. Fortunately, a transformation of the intensity to a volume or mass distribution can be accomplished using Mie theory, wherein the optical properties of the analyte are used to normalize the effects of the R6 dependence of the scattering intensity. The assumptions required for the intensity to mass transformation include:
- The particles can be modeled as spheres.
- All particles have an equivalent and homogeneous density.
- There is no error in the intensity particle size distribution.
For many applications relevant to biopharmaceuticals, the first 2 assumptions are reasonable. The third assumption, however, will always fail, due to the ill-posed nature of the correlogram fitting in the DLS technique. In other words, regardless of how monodisperse the sample is, the DLS-measured distribution will always have a small degree of inherent polydispersity, i.e. you'll never be able to achieve a single band distribution as one might achieve using TEM measurements. As such, the volume transformation should not be used to report particle size, but rather to report the relative mass composition.
Figure 4 shows a comparison of the DLS-derived intensity and mass distributions for ovalbumin in PBS at 79°C. Two size populations are evident in this example - one at 6.0 nm and the other at 46 nm. By intensity, the larger particle size family dominates the distribution, even though it represents only 6% of the total mass of the sample. When reporting results for this measurement, the appropriate peak mean sizes to report would be those derived from the intensity distribution, with the %mass values used to report composition information, e.g. 5.95 nm and 46.0 nm with a relative mass composition of 93% and 6% respectively.
Figure 4: Comparison of DLS derived intensity and mass distributions for ovalbumin in PBS at 79°C.
- Benight, Wilson, Budzynski, & Goldstein "Dynamic light scattering investigations of RecA self-assembly and interactions with single strand DNA", Biochimie 1991, 73(2-3), 143-155.
- Brown "Miniature Laser Light Scattering Instrumentation for Particle Size Analysis", Applied Optics 1990, 29(28), 1.
- D'Arcy "Crystallizing proteins", Acta Cryst. 1994, D50, 467-471.
- Fusett & Dijkstra "Purification and light-scattering analysis of penicillin-binding protein 4 from Escherichia coli", Microbial Drug Resistance 1996, 2(1), 73-76.
- Hutchinson, Francis, Lyle, & Jones "The characterization of liposomes with covalently attached proteins", Biochim. Biophys. Acta 1989, 978(1), 17-24.
- Moradian-Oldak, Leung, & Fincham "Temperature and pH-dependent supramolecular self-assembly of amelogenin molecules: a dynamic light-scattering analysis", Journal Of Strucural Biology 1998, 122(3) 320-327.
- Pecora "Dynamic Light Scattering: Applications of Photon Correlation Spectroscopy", Plenum Press, 1985.
- Piekenbrock & Sackmann "Quasielastic light scattering study of thermal excitations of F-actin solutions and of growth kinetics of actin filaments", Biopolymers 1992, 32(11), 1471-1489.
- Sam, Pley, & Mandel "A hydrodynamic study with quasielastic light scattering and sedimentation of bacterial elongation factor EF-Tu.guanosine-5'-diphosphate complex under nonassociating conditions", Biopolymers 1990, 30(3-4), 299-308.
- Santos, Sousa, Betbeder, Prieto, & Castanho, "Structural characterization of organized systems of polysaccharides and phospholipids by light scattering, spectroscopy, and electron microscopy", Carbohydrate Research 1997, 300(1), 31-40.
- "A basic guide to particle characterization". Inform White Paper, Malvern Instruments Limited.
- "Developing a bioformulation stability profile". Inform White Paper, Malvern Instruments Limited.
About Malvern's Bioscience Development Initiative
Malvern Instruments' Bioscience Development Initiative was established to accelerate innovation, development, and the promotion of novel technologies, products, and capabilities to address unmet measurement needs in the biosciences markets.